{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:39:14Z","timestamp":1791189554924,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.numecd.2015.02.001","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T01:46:01Z","timestamp":1423705561000},"page":"519-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["The lipid theory in the pathogenesis of calcific aortic stenosis"],"prefix":"10.1016","volume":"25","author":[{"given":"V.","family":"Parisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Leosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"de Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Perrone Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2015.02.001_bib1","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC)","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2015.02.001_bib2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/CIRCULATIONAHA.106.657759","article-title":"Calcific aortic stenosis: a disease ready for prime time","volume":"114","author":"Rajamannan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.CIR.0000070591.21548.69","article-title":"Human aortic valve calcification is associated with an osteoblast phenotype","volume":"107","author":"Rajamannan","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.ATV.19.5.1218","article-title":"Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves","volume":"19","author":"Olsson","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2015.02.001_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMc031360","article-title":"Hypercholesterolemic aortic-valve disease","volume":"349","author":"Rajamannan","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2015.02.001_bib6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular health study","volume":"29","author":"Stewart","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0002-9149(01)01501-6","article-title":"Prevalence of CAD in patients with aortic stenosis with and without angina pectoris","volume":"87","author":"Rapp","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/hrt.51.2.121","article-title":"Prevalence of CAD in patients with isolated aortic valve stenosis","volume":"51","author":"Exadactylos","year":"1984","journal-title":"Br Heart J"},{"key":"10.1016\/j.numecd.2015.02.001_bib9","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.jacc.2005.12.073","article-title":"Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis","volume":"47","author":"Briand","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00223-006-0052-0","article-title":"Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: the health, aging, and body composition study","volume":"79","author":"Farhat","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2015.02.001_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00223-008-9153-2","article-title":"Relationship of calcification of atherosclerotic plaque and arterial stiffness to bone mineral density and osteoprotegerin in postmenopausal women referred for osteoporosis screening","volume":"83","author":"Frost","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2015.02.001_bib12","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1359\/jbmr.060903","article-title":"Volumetric BMD and vascular calcification in middle-aged women: the study of women's health across the nation","volume":"21","author":"Farhat","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2015.02.001_bib13","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcb.24031","article-title":"Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS(-\/-) null mice","volume":"113","author":"Rajamannan","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.numecd.2015.02.001_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.ATV.16.4.523","article-title":"Apolipoproteins B,(a), and E accumulate in the morphologically early lesion of degenerative valvular aortic stenosis","volume":"16","author":"O'Brien","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2015.02.001_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jss.2013.05.001","article-title":"ox-LDL induces PiT-1 expression in human aortic valve interstitial cells","volume":"184","author":"Nadlonek","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.numecd.2015.02.001_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/ATVBAHA.107.154989","article-title":"Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis","volume":"28","author":"Mohty","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2015.02.001_bib17","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2014.13959","article-title":"Cohorts for heart and aging research in genetic epidemiology (CHARGE) extracoronary calcium working group. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis","volume":"312","author":"Smith","year":"2014","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.numecd.2015.02.001_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ahj.2003.11.011","article-title":"Lipid profile of patients with aortic stenosis might be predictive of rate of progression","volume":"147","author":"Yilmaz","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2015.02.001_bib19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.atherosclerosis.2011.08.027","article-title":"High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification","volume":"219","author":"Lommi","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2015.02.001_bib20","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2015.02.001_bib21","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipopro- tein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2015.02.001_bib22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2559.2012.04265.x","article-title":"Amyloid substance within stenotic aortic valves promotes mineralization","volume":"61","author":"Audet","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.numecd.2015.02.001_bib23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/bjp.2008.122","article-title":"Regression of aortic valve stenosis by ApoA-I mimetic peptide infusions in rabbits","volume":"154","author":"Busseuil","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.numecd.2015.02.001_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4252\/wjsc.v5.i4.136","article-title":"Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts","volume":"5","author":"Fakhry","year":"2013","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.numecd.2015.02.001_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1534-5807(02)00157-0","article-title":"Reaching a genetic and molecular understanding of skeletal development","volume":"2","author":"Karsenty","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.numecd.2015.02.001_bib26","first-page":"254","article-title":"Identification and characterization of calcifying valve cells from human and canine aortic valves","volume":"8","author":"Mohler","year":"1999","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.numecd.2015.02.001_bib27","doi-asserted-by":"crossref","first-page":"I229","DOI":"10.1161\/01.CIRCULATIONAHA.104.524306","article-title":"Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway","volume":"112","author":"Rajamannan","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib28","doi-asserted-by":"crossref","first-page":"H5","DOI":"10.1152\/ajpheart.00824.2009","article-title":"Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology","volume":"298","author":"Rajamannan","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ndt\/gfm660","article-title":"Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease","volume":"23","author":"Toussaint","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.numecd.2015.02.001_bib30","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/HYPERTENSIONAHA.107.086942","article-title":"Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients","volume":"49","author":"Raggi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2015.02.001_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-005-0250-1","article-title":"Increased arterial calcification in Paget's disease of bone","volume":"77","author":"Laroche","year":"2005","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2015.02.001_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.molmed.2009.07.001","article-title":"Vascular calcification and bone disease: the calcification paradox","volume":"15","author":"Persy","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.numecd.2015.02.001_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00223-007-9004-6","article-title":"Wright. Association between systemic calcified atherosclerosis and bone density","volume":"80","author":"Hyder","year":"2007","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.numecd.2015.02.001_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00019501-200509000-00007","article-title":"Aortic valve calcification: association with bone mineral density and cardiovascular risk factors","volume":"16","author":"Aksoy","year":"2005","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.numecd.2015.02.001_bib35","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/eurheartj\/ehq237","article-title":"Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation","volume":"31","author":"Hjortnaes","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2015.02.001_bib36","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1002\/jcb.23221","article-title":"The role of Lrp5\/6 in cardiac valve disease: experimental hypercholesterolemia in the ApoE\u2212\/\u2212\/Lrp5\u2212\/\u2212 mice","volume":"112","author":"Rajamannan","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.numecd.2015.02.001_bib37","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(87)91370-5","article-title":"Aortic and mitral valve calcification in patients with end-stage renal disease","volume":"2","author":"Maher","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2015.02.001_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacc.2008.05.043","article-title":"Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans","volume":"52","author":"Miller","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jacc.2013.05.105","article-title":"Elevated expression of Lp-PLA2 in calcific aortic valve disease: implication for valve mineralization","volume":"63","author":"Mahmut","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jacc.2013.08.1639","article-title":"New therapeutic targets for calcific aortic valve stenosis: the lipoprotein (a), lipoprotein-associated phospholipase a, oxidized phospholipid axis","volume":"63","author":"Hung","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein (a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib42","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.2353\/ajpath.2010.090541","article-title":"Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via toll-like receptor 2","volume":"176","author":"Derbali","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.numecd.2015.02.001_bib43","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/01.CIR.0000035655.45453.D2","article-title":"Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma","volume":"106","author":"O'Brien","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/HYPERTENSIONAHA.108.110320","article-title":"Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease","volume":"53","author":"Mathieu","year":"2009","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.numecd.2015.02.001_bib45","article-title":"Epicardial fat tissue: a potential role in aortic stenosis pathogenesis","volume":"63","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib46","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jacc.2006.02.040","article-title":"Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein5 receptor-mediated bone formation","volume":"47","author":"Caira","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/hrt.2003.029785","article-title":"Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve","volume":"91","author":"Rajamannan","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.numecd.2015.02.001_bib48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"Osteoporosis-pseudoglioma syndrome collaborative group. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.numecd.2015.02.001_bib49","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1359\/jbmr.040907","article-title":"Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6","volume":"19","author":"Holmen","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2015.02.001_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2004.06.044","article-title":"Wnt signaling in osteoblasts and bone diseases","volume":"341","author":"Westendorf","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.numecd.2015.02.001_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11154-006-9002-4","article-title":"Wnt signaling and osteoblastogenesis","volume":"7","author":"Bodine","year":"2006","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.numecd.2015.02.001_bib52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1998.9788","article-title":"RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis","volume":"253","author":"Nakagawa","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.numecd.2015.02.001_bib53","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2015.02.001_bib54","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/ATVBAHA.107.147868","article-title":"Role of osteoprotegerin in arterial calci\ufb01cation: development of new animal model","volume":"27","author":"Orita","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2015.02.001_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yjmcc.2003.09.015","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification","volume":"36","author":"Kaden","year":"2004","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2015.02.001_bib56","doi-asserted-by":"crossref","first-page":"e65201","DOI":"10.1371\/journal.pone.0065201","article-title":"Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice","volume":"6:8","author":"Weiss","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2015.02.001_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.clim.2009.07.011","article-title":"Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss","volume":"133","author":"Graham","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.numecd.2015.02.001_bib58","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/jbmr.148","article-title":"Bone density and hyperlipidemia: the T-lymphocyte connection","volume":"25","author":"Graham","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.numecd.2015.02.001_bib59","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1161\/CIRCULATIONAHA.108.834614","article-title":"Lowering plasma cholesterol levels halts progression of aortic valve disease in mice","volume":"119","author":"Miller","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib60","first-page":"18","article-title":"The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aorticstenosis","volume":"20","author":"Dimitrow","year":"2011","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.numecd.2015.02.001_bib61","first-page":"337","article-title":"The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality","volume":"21","author":"Ardehali","year":"2012","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.numecd.2015.02.001_bib62","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","article-title":"Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis","volume":"49","author":"Moura","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib63","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1161\/hc4301.098249","article-title":"Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic valve stenosis","volume":"104","author":"Novaro","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib64","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000140723.15274.53","article-title":"Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis","volume":"110","author":"Rosenhek","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib65","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2015.02.001_bib66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2015.02.001_bib67","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis. Results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib68","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/bmj.328.7441.711-b","article-title":"Exercise training metanalysis of trials in patients with chronic heart failure (ExTraMATCH)","volume":"328","author":"Piepoli","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.numecd.2015.02.001_bib69","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0735-1097(93)90051-2","article-title":"Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions","volume":"22","author":"Hambrecht","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2015.02.001_bib70","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1161\/01.CIR.0000074229.93804.5C","article-title":"Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase","volume":"107","author":"Hambrecht","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib71","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.CIR.0000154560.88933.7E","article-title":"Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease","volume":"111","author":"Adams","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvm109","article-title":"Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart","volume":"78","author":"Leosco","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.numecd.2015.02.001_bib73","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.109.892224","article-title":"Regular exercise training prevents aortic valve disease in low-density lipoprotein-receptor-deficient mice","volume":"121","author":"Matsumoto","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.02.001_bib74","doi-asserted-by":"crossref","first-page":"e37298","DOI":"10.1371\/journal.pone.0037298","article-title":"Regular exercise or changing diet does not influence aortic valve disease progression in LDLR deficient mice","volume":"7","author":"Schlotter","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2015.02.001_bib75","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/eht055","article-title":"HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin\/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment","volume":"34","author":"HPS2-THRIVE Collaborative Group","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2015.02.001_bib76","unstructured":"A study of evacetrapib in high-risk vascular disease (ACCELERATE). ClinicalTrials.gov Identifier: NCT01687998."},{"key":"10.1016\/j.numecd.2015.02.001_bib77","unstructured":"REVEAL: randomized evaluation of the effects of anacetrapib through lipid-modification. ClinicalTrials.gov Identifier: NCT01252953."},{"key":"10.1016\/j.numecd.2015.02.001_bib78","article-title":"PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial","author":"Raal","year":"2014","journal-title":"Lancet"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T04:57:08Z","timestamp":1717736228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475315000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0939475315000320"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2015.02.001","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The lipid theory in the pathogenesis of calcific aortic stenosis","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2015.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}